Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Provez L, Putteman T, Landfors M, Roels J, Reunes L, T'Sas S, Van Loocke W, Lintermans B, De Coninck S, Thenoz M, Sleeckx W, Maćkowska-Maślak N, Taghon T, Mansour MR, Farah N, Norga K, Vandenberghe P, Kotecha RS, Goossens S, Degerman S, De Smedt R, Van Vlierberghe P.
Provez L, et al. Among authors: taghon t, t sas s.
Cancers (Basel). 2023 Jan 20;15(3):647. doi: 10.3390/cancers15030647.
Cancers (Basel). 2023.
PMID: 36765607
Free PMC article.